Login / Signup

Primary cutaneous mucormycosis in a premature neonate treated conservatively with amphotericin B.

Stephany L VittitowCorina A RusuMaryam O AbubakarJennifer BurnsedAlejandro A GruBarrett J Zlotoff
Published in: Pediatric dermatology (2021)
Cutaneous mucormycosis is a rare, often fatal fungal infection that most commonly affects patients with underlying immunosuppression but also can occur in premature neonates. We report the case of an extremely premature boy (<25 weeks) who developed primary cutaneous mucormycosis shortly after birth. Although surgical debridement has been a mainstay of treatment in combination with antifungal therapy, our patient was successfully treated with amphotericin B alone-the management only reported in three other cases to date. We present this case to highlight that prompt initiation of treatment with amphotericin B alone may be an appropriate alternative to surgical intervention, particularly in patients with non-angioinvasive disease who are poor surgical candidates.
Keyphrases
  • randomized controlled trial
  • pregnant women
  • mesenchymal stem cells
  • candida albicans
  • smoking cessation